North Star Asset Management’s Idexx Laboratories IDXX Stock Holding History

North Star Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$465K	Sell	884 -8	-0.9%	-$4.49K	0.02%	258
2026 Q1	$501K	Hold	892	–	–	0.02%	249
2025 Q4	$603K	Sell	892 -42	-4%	-$28.6K	0.02%	219
2025 Q3	$597K	Hold	934	–	–	0.02%	219
2025 Q2	$501K	Hold	934	–	–	0.02%	224
2025 Q1	$392K	Sell	934 -5	-0.5%	-$2.17K	0.02%	237
2024 Q4	$388K	Buy	939 +526	+127%	+$231K	0.02%	238
2024 Q3	$209K	Sell	413 -5	-1%	-$2.43K	0.01%	305
2024 Q2	$204K	Hold	418	–	–	0.01%	297
2024 Q1	$226K	Sell	418 -2	-0.5%	-$1.09K	0.01%	288
2023 Q4	$233K	Buy	+420	New	+$197K	0.01%	274
2023 Q3	–	Sell	-420	Closed	-$211K	–	301
2023 Q2	$211K	Hold	420	–	–	0.01%	276
2023 Q1	$210K	Buy	+420	New	+$201K	0.01%	280
2022 Q2	–	Sell	-420	Closed	-$230K	–	301
2022 Q1	$230K	Hold	420	–	–	0.01%	281
2021 Q4	$277K	Hold	420	–	–	0.01%	269
2021 Q3	$261K	Sell	420 -10	-2%	-$6.72K	0.01%	262
2021 Q2	$272K	Hold	430	–	–	0.02%	265
2021 Q1	$210K	Hold	430	–	–	0.01%	267
2020 Q4	$215K	Buy	+430	New	+$192K	0.01%	259

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

North Star Asset Management's IDXX Position: Q2 2026 in Review

North Star Asset Management reduced its Idexx Laboratories (IDXX) stake by 0.9% in Q2 2026, selling an estimated $4.49K and leaving 884 shares worth $465K. The position accounts for 0.02% of the portfolio, ranked #258.

North Star Asset Management first reported a position in IDXX in Q4 2020 and has held it in 19 quarters since. The position peaked at $603K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

North Star Asset Management held 884 shares of Idexx Laboratories worth $465K as of Q2 2026.
North Star Asset Management sold 8 Idexx Laboratories shares in Q2 2026, an estimated $4.49K.
Idexx Laboratories made up 0.02% of North Star Asset Management's portfolio in Q2 2026, its #258 holding.
North Star Asset Management first reported a position in Idexx Laboratories in Q4 2020 and has held it in 19 quarters since.
North Star Asset Management's Idexx Laboratories position peaked at $603K in Q4 2025.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on North Star Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.